4//SEC Filing
O'Kane Kieran 4
Accession 0000905148-25-003931
CIK 0001439725other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 4:53 PM ET
Size
8.8 KB
Accession
0000905148-25-003931
Insider Transaction Report
Form 4
BIODESIX INCBDSX
O'Kane Kieran
Chief Commercial Officer
Transactions
- Sale
Common Stock
2025-11-10$7.62/sh−25$191→ 7,362 total - Exercise/Conversion
Common Stock
2025-11-10+75→ 7,387 total - Exercise/Conversion
Restricted Stock Units
2025-11-10−75→ 73 total→ Common Stock (75 underlying)
Footnotes (5)
- [F1]These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025 (the "Reverse Stock Split").
- [F2]Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F3]Includes 309 shares of the Issuer's Common Stock, as adjusted for the Reverse Stock Split, purchased under the Issuer's Employee Stock Purchase Plan on September 2, 2025.
- [F4]These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs.
- [F5]These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
Documents
Issuer
BIODESIX INC
CIK 0001439725
Entity typeother
Related Parties
1- filerCIK 0001828131
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 4:53 PM ET
- Size
- 8.8 KB